3:I[4707,[],""]
5:I[36423,[],""]
6:I[68590,["851","static/chunks/851-eac4590c87d92c5e.js","503","static/chunks/503-e2812d07ee5c6be0.js","933","static/chunks/933-a45b0cad1b2326ab.js","861","static/chunks/861-49f5a2cac526f5e8.js","490","static/chunks/app/vt/layout-03dc44bfe6d9302b.js"],"default",1]
7:I[35956,["851","static/chunks/851-eac4590c87d92c5e.js","185","static/chunks/app/layout-2650b2d70eac3e73.js"],"MantineProvider"]
4:["slug","buczynski-matthew","d"]
0:["ZsbTZ_CMmbgxGhMlcA0JX",[[["",{"children":["vt",{"children":["instructors",{"children":[["slug","buczynski-matthew","d"],{"children":["__PAGE__?{\"slug\":\"buczynski-matthew\"}",{}]}]}]}]},"$undefined","$undefined",true],["",{"children":["vt",{"children":["instructors",{"children":[["slug","buczynski-matthew","d"],{"children":["__PAGE__",{},[["$L1","$L2",null],null],null]},[null,["$","$L3",null,{"parallelRouterKey":"children","segmentPath":["children","vt","children","instructors","children","$4","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L5",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[null,["$","$L3",null,{"parallelRouterKey":"children","segmentPath":["children","vt","children","instructors","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L5",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[[null,["$","$L6",null,{"children":["$","$L3",null,{"parallelRouterKey":"children","segmentPath":["children","vt","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L5",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}],"params":{}}]],null],null]},[[[["$","link","0",{"rel":"stylesheet","href":"/_next/static/css/c77d545bfa368e07.css","precedence":"next","crossOrigin":"$undefined"}],["$","link","1",{"rel":"stylesheet","href":"/_next/static/css/4bbadacbad84da46.css","precedence":"next","crossOrigin":"$undefined"}]],["$","html",null,{"lang":"en","children":[null,["$","body",null,{"children":["$","$L7",null,{"theme":{},"children":["$","$L3",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L5",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":[["$","title",null,{"children":"404: This page could not be found."}],["$","div",null,{"style":{"fontFamily":"system-ui,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif,\"Apple Color Emoji\",\"Segoe UI Emoji\"","height":"100vh","textAlign":"center","display":"flex","flexDirection":"column","alignItems":"center","justifyContent":"center"},"children":["$","div",null,{"children":[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}"}}],["$","h1",null,{"className":"next-error-h1","style":{"display":"inline-block","margin":"0 20px 0 0","padding":"0 23px 0 0","fontSize":24,"fontWeight":500,"verticalAlign":"top","lineHeight":"49px"},"children":"404"}],["$","div",null,{"style":{"display":"inline-block"},"children":["$","h2",null,{"style":{"fontSize":14,"fontWeight":400,"lineHeight":"49px","margin":0},"children":"This page could not be found."}]}]]}]}]],"notFoundStyles":[]}]}]}]]}]],null],null],["$L8",null]]]]
8:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}],["$","meta","1",{"charSet":"utf-8"}],["$","title","2",{"children":"Odysseus Advisor"}],["$","meta","3",{"name":"description","content":"description"}],["$","link","4",{"rel":"icon","href":"/favicon.ico","type":"image/x-icon","sizes":"256x256"}]]
1:null
9:I[96580,["851","static/chunks/851-eac4590c87d92c5e.js","503","static/chunks/503-e2812d07ee5c6be0.js","780","static/chunks/780-ddc6a6dc4d1e4a45.js","60","static/chunks/app/vt/instructors/%5Bslug%5D/page-54778bd7b299f250.js"],"default"]
2:["$","$L9",null,{"instructor":{"id":"buczynski-matthew","firstName":"Matthew","lastName":"Buczynski","difficulty":5.5,"rating":9.9,"recommendedPct":100,"numRatings":2,"sectionsTaught":17,"courses":[{"id":"NEUR-2994","subject":"NEUR","code":"2994","level":2,"title":"Undergraduate Research","coreqs":"","repeatability":"","description":"","pathways":"","hours":"1-19 credits","groupId":6823,"sections":[{"id":"2018;01;16720","instructorName":"buczynski-matthew","course_id":"NEUR-2994","credits":"  2","crn":16720,"enrollment":5,"gpa":4,"term":"Spring","title":"Undergraduate Research","year":2018,"gradeData":[100,0,0,0,0,0,0,0,0,0,0,0,0]},{"id":"2020;09;88668","instructorName":"buczynski-matthew","course_id":"NEUR-2994","credits":"  3","crn":88668,"enrollment":6,"gpa":4,"term":"Fall","title":"Undergraduate Research","year":2020,"gradeData":[100,0,0,0,0,0,0,0,0,0,0,0,0]}]},{"id":"NEUR-3914","subject":"NEUR","code":"3914","level":3,"title":"Neuroscience of Drug Addiction","coreqs":"","repeatability":"","description":"History of addiction as a chronic, relapsing brain disease. Neurocircuitry and molecular basis of the brain affected by common drugs of abuse.  Overview of the use, abuse, liability, and psychotherapeutic effects of drugs on humans. Common classes of drug abuse: alcohol, sedatives, tobacco/ nicotine, opiods, cannabinoids, psychostimulants, psychedelics, steroids, anti-anxiety, antidepressants, and antipsychotics.  Animal models in drug addiction studies. Current and future pharmacotherapeutics for drug addiction treatment and ethical considerations of treatments.","pathways":"","hours":"3 credits","groupId":6840,"sections":[{"id":"2019;01;17054","instructorName":"buczynski-matthew","course_id":"NEUR-3914","credits":"  3","crn":17054,"enrollment":60,"gpa":3.52,"term":"Spring","title":"Neuroscience of Drug Addiction","year":2019,"gradeData":[65,0,0,26.7,0,0,3.3,0,0,5,0,0,0]},{"id":"2023;01;18492","instructorName":"buczynski-matthew","course_id":"NEUR-3914","credits":"  3","crn":18492,"enrollment":94,"gpa":3.08,"term":"Spring","title":"Neuroscience of Drug Addiction","year":2023,"gradeData":[35.1,1.1,0,44.7,0,0,11.7,0,0,6.4,0,1.1,0]},{"id":"2022;01;18220","instructorName":"buczynski-matthew","course_id":"NEUR-3914","credits":"  3","crn":18220,"enrollment":127,"gpa":3.16,"term":"Spring","title":"Neuroscience of Drug Addiction","year":2022,"gradeData":[43.3511811023622,0,0,33.09921259842519,0,0,15.71968503937008,0,0,4.686614173228346,0,0.7811023622047244,2.362204724409449]},{"id":"2020;01;17800","instructorName":"buczynski-matthew","course_id":"NEUR-3914","credits":"  3","crn":17800,"enrollment":128,"gpa":3.52,"term":"Spring","title":"Neuroscience of Drug Addiction","year":2020,"gradeData":[60.2,0,0,32,0,0,7,0,0,0.8,0,0,0]},{"id":"2021;01;18424","instructorName":"buczynski-matthew","course_id":"NEUR-3914","credits":"  3","crn":18424,"enrollment":142,"gpa":3.52,"term":"Spring","title":"Neuroscience of Drug Addiction","year":2021,"gradeData":[59.89999999999999,0,0,34.5,0,0,4.2,0,0,0.7,0,0.7,0]},{"id":"2018;01;19403","instructorName":"buczynski-matthew","course_id":"NEUR-3914","credits":"  3","crn":19403,"enrollment":32,"gpa":3.58,"term":"Spring","title":"Neuroscience of Drug Addiction","year":2018,"gradeData":[59.384375,0,0,34.390625,0,0,3.1,0,0,0,0,0,3.125]}]},{"id":"NEUR-4914","subject":"NEUR","code":"4914","level":4,"title":"Drug Development in Neuroscience","coreqs":"","repeatability":"","description":"Current approaches and pitfalls for developing therapeutics for treating disorders of the central nervous system (CNS). Theoretical issues and practical applications targeting identification, high-throughput screening, pharmacokinetics and pharmacodynamics, preclinical testing, clinical trials, and the FDA approval process. Ethical implications for drug development and testing.","pathways":"","hours":"3 credits","groupId":6849,"sections":[{"id":"2024;01;18533","instructorName":"buczynski-matthew","course_id":"NEUR-4914","credits":"  3","crn":18533,"enrollment":13,"gpa":3.5,"term":"Spring","title":"Drug Development in Neurosci","year":2024,"gradeData":[30.8,30.8,0,30.8,7.700000000000001,0,0,0,0,0,0,0,0]},{"id":"2022;01;18229","instructorName":"buczynski-matthew","course_id":"NEUR-4914","credits":"  3","crn":18229,"enrollment":7,"gpa":3.81,"term":"Spring","title":"Drug Development in Neurosci","year":2022,"gradeData":[57.1,28.6,14.3,0,0,0,0,0,0,0,0,0,0]},{"id":"2021;01;18434","instructorName":"buczynski-matthew","course_id":"NEUR-4914","credits":"  3","crn":18434,"enrollment":16,"gpa":3.74,"term":"Spring","title":"Drug Development in Neurosci","year":2021,"gradeData":[49.96875,25.03125,6.28125,12.46875,0,0,0,0,0,0,0,0,6.25]},{"id":"2020;01;19931","instructorName":"buczynski-matthew","course_id":"NEUR-4914","credits":"  3","crn":19931,"enrollment":16,"gpa":3.79,"term":"Spring","title":"Drug Development in Neurosci","year":2020,"gradeData":[68.8,12.5,12.5,0,6.3,0,0,0,0,0,0,0,0]},{"id":"2023;01;18503","instructorName":"buczynski-matthew","course_id":"NEUR-4914","credits":"  3","crn":18503,"enrollment":8,"gpa":3.5,"term":"Spring","title":"Drug Development in Neurosci","year":2023,"gradeData":[62.5,0,0,25,0,0,12.5,0,0,0,0,0,0]}]},{"id":"NEUR-4984","subject":"NEUR","code":"4984","level":4,"title":"Special Study","coreqs":"","repeatability":"","description":"","pathways":"","hours":"1-19 credits","groupId":6851,"sections":[{"id":"2019;01;19758","instructorName":"buczynski-matthew","course_id":"NEUR-4984","credits":"  3","crn":19758,"enrollment":17,"gpa":3.71,"term":"Spring","title":"SS:Drug Devlpmnt in Neur","year":2019,"gradeData":[64.7,11.8,11.8,5.9,0,0,5.9,0,0,0,0,0,0]},{"id":"2017;01;19483","instructorName":"buczynski-matthew","course_id":"NEUR-4984","credits":"  3","crn":19483,"enrollment":38,"gpa":3.03,"term":"Spring","title":"SS: Neuroscience of Addiction","year":2017,"gradeData":[34.2,0,0,36.85263157894737,0,0,18.37894736842105,0,0,2.652631578947368,0,2.652631578947368,5.263157894736842]},{"id":"2018;01;19653","instructorName":"buczynski-matthew","course_id":"NEUR-4984","credits":"  3","crn":19653,"enrollment":6,"gpa":4,"term":"Spring","title":"SS: Drug Devlpmnt in Neur","year":2018,"gradeData":[100,0,0,0,0,0,0,0,0,0,0,0,0]}]},{"id":"NEUR-5914","subject":"NEUR","code":"5914","level":5,"title":"Drug Development in Neuroscience","coreqs":"","repeatability":"","description":"Current approaches and pitfalls for developing therapeutics for treating disorders of the central nervous system (CNS). Theoretical issues and practical applications targeting identification, high-throughput screening, pharmacokinetics and pharmacodynamics, preclinical testing, clinical trials, and the FDA approval process.  Ethical implications for drug development and testing.  Pre: Graduate Standing.","pathways":"","hours":"3 credits","groupId":6866,"sections":[{"id":"2022;01;18261","instructorName":"buczynski-matthew","course_id":"NEUR-5914","credits":"  3","crn":18261,"enrollment":6,"gpa":3.95,"term":"Spring","title":"Drug Development in Neurosci","year":2022,"gradeData":[83.3,16.7,0,0,0,0,0,0,0,0,0,0,0]}]}]}}]
